Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.

Journal: British journal of haematology
PMID:

Abstract

The subjectivity of morphological assessment and the overlapping pathological features of different subtypes of myeloproliferative neoplasms (MPNs) make accurate diagnosis challenging. To improve the pathological assessment of MPNs, we developed a diagnosis model (fusion model) based on the combination of bone marrow whole-slide images (deep learning [DL] model) and clinical parameters (clinical model). Thousand and fifty-one MPN and non-MPN patients were divided into the training, internal testing and one internal and two external validation cohorts (the combined validation cohort). In the combined validation cohort, fusion model achieved higher areas under curve (AUCs) than clinical or DL model or both for MPNs and subtype identification. Compared with haematopathologists with different experience, clinical model achieved AUC which was comparable to seniors and higher than juniors (p = 0.0208) for polycythaemia vera. The AUCs of fusion model were comparable to seniors and higher than juniors for essential thrombocytosis (p = 0.0141), prefibrotic primary myelofibrosis (p = 0.0085) and overt primary myelofibrosis (p = 0.0330) identification. In conclusion, the performances of our proposed models are equivalent to senior haematopathologists and better than juniors, providing a new perspective on the utilization of DL algorithms in MPN morphological assessment.

Authors

  • Rong Wang
    College of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shanxi, China. Electronic address: wangrong91@nwsuaf.edu.cn.
  • Zhongxun Shi
    Department of Haematology, Collaborative Innovation Center for Cancer Personalized Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Yuan Zhang
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liangmin Wei
    Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Minghui Duan
    Department of Haematology, Peking Union Medical College Hospital, Beijing, China.
  • Min Xiao
  • Jin Wang
    Cells Vision (Guangzhou) Medical Technology Inc., Guangzhou, China. Electronic address: wangjin@cellsvision.com.
  • Suning Chen
    NHC Key Laboratory of Thrombosis and Hemostasis, National Clinical Research Center for Haematologic Diseases, Jiangsu Institute of Haematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Qian Wang
    Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • Jianyao Huang
    Department of Haematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xiaomei Hu
    Center for SCDM, School of Media and Law, NingboTech University, Ningbo 315100, China.
  • Jinhong Mei
    The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Jieyu He
    Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Feng Chen
    Department of Integrated Care Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Lei Fan
    Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543, Singapore.
  • Guanyu Yang
    Laboratory of Image Science and Technology, School of Computer Science and Engineering, Southeast University, Nanjing, China; Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education, Nanjing, China; Centre de Recherche en Information Biomedicale Sino-Francais (LIA CRIBs), Rennes, France.
  • Wenyi Shen
    Department of Haematology, Collaborative Innovation Center for Cancer Personalized Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Yongyue Wei
    Department of Biostatistics, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Jianyong Li